What are the signs and symptoms of varicella-zoster virus (VZV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Varicella-Zoster Virus (VZV) Infection

Varicella-zoster virus infection presents with distinct clinical manifestations depending on whether it's a primary infection (chickenpox) or reactivation (herpes zoster/shingles), characterized primarily by fever and vesicular skin lesions that progress through multiple stages of development.

Primary VZV Infection (Chickenpox)

Incubation and Prodromal Phase

  • Incubation period averages 14-16 days (range: 10-21 days) after exposure to the virus 1
  • Infected persons are contagious approximately 1-2 days before rash onset until all lesions are crusted 1
  • Prodromal symptoms may include fever, malaise, and symptoms resembling upper respiratory tract infection 1

Characteristic Rash

  • Cutaneous lesions begin as macules and rapidly progress through stages: papules, vesicles, pustules, and finally scabs 1
  • Rash typically starts on the trunk and head, then spreads to extremities (centripetal distribution) 1
  • Most children develop 250-500 skin lesions in the classic form of disease 1
  • Lesions appear in successive crops, with multiple stages of development present simultaneously 1, 2
  • Fever and rash typically last approximately 5 days 1

Other Clinical Features

  • Lesions frequently develop in the mouth, conjunctivae, or other mucosal sites 1
  • Secondary bacterial skin infections may occur as a complication 3
  • In vaccinated individuals (breakthrough varicella), the presentation is often modified with fewer lesions (<50), predominantly maculopapular rather than vesicular, milder fever, and shorter illness duration 1

VZV Reactivation (Herpes Zoster/Shingles)

Prodromal Phase

  • Prodromal pain often precedes skin findings by 24-72 hours 4
  • Pain may be accompanied by tingling, itching, or burning in the affected dermatome 5, 6

Characteristic Rash

  • Unilateral, dermatomal distribution of vesicular lesions 1, 4
  • Lesions progress from erythematous macules to papules and then to vesicles, which may coalesce and form bullae before scabbing 4
  • Vesicles continue to erupt for 4-6 days with total disease duration of approximately 2 weeks in immunocompetent hosts 4
  • In immunocompromised patients, skin lesions may develop over a longer period (7-14 days) and heal more slowly 4

Distinctive Signs

  • Pleomorphic or non-excavated pseudodendritic epithelial keratitis of cornea or conjunctiva may be present in ocular involvement 1
  • Vesicular dermatomal rash or ulceration of eyelids in ophthalmic zoster 1

Complications

Post-Herpetic Neuralgia

  • Chronic pain persisting after the rash heals, more common in older adults 5, 7
  • Most frequent and important complication of VZV reactivation 6

Neurological Complications

  • VZV reactivation can cause various neurological syndromes including vasculitis, encephalitis, myelopathy, and cranial neuropathies 6
  • Zoster sine herpete: VZV reactivation without the characteristic rash 6

Ocular Complications

  • Conjunctival scarring, keratitis, corneal scarring, uveitis, and retinitis may occur 1
  • Necrosis and scarring from vesicles on the eyelid margins 1

Complications in Immunocompromised Patients

  • Higher risk of disseminated disease with involvement of multiple organs including liver and brain 3
  • Without adequate treatment, chronic ulcerations with persistent viral replication may develop, complicated by secondary bacterial and fungal superinfections 4

Special Considerations

  • Adult cases tend to be more severe than childhood cases 3
  • Immunocompromised individuals have higher risk of complications 4, 3
  • Pregnant women may experience more severe disease due to altered immune response 3

Understanding these clinical manifestations is crucial for prompt diagnosis and appropriate management of VZV infections to prevent complications and reduce morbidity.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Varicella-zoster virus.

Clinical microbiology reviews, 1996

Guideline

Management of Herpes Zoster Reactivation in Individuals with Varicella Antibodies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Complications of varicella zoster virus reactivation.

Current treatment options in neurology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.